Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams
from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.
Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.
The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.
China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.
Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2 ...
Table of Contents
2019-2024 Global Argatroban Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Argatroban Consumption 2014-2024
2.1.2 Argatroban Consumption CAGR by Region
2.2 Argatroban Segment by Type
2.2.1 Argatroban Powder
2.2.2 Argatroban Injection
2.3 Argatroban Consumption by Type
2.3.1 Global Argatroban Consumption Market Share by Type (2014-2019)
2.3.2 Global Argatroban Revenue and Market Share by Type (2014-2019)
2.3.3 Global Argatroban Sale Price by Type (2014-2019)
2.4 Argatroban Segment by Application
2.4.1 Heparin-induced thrombocytopenia (HIT)
2.4.2 Percutaneous Coronary Intervention
2.4.3 Cerebral arterial thrombosis
2.5 Argatroban Consumptio ...